CD140a, Human (Olaratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.

Search, find, compare suppliers for anti-CD140a, Human (Olaratumab biosimilar) antibody, protein, ELISA kits.

Edit 
Antigenic SpecificityCD140a, Human (Olaratumab biosimilar)
CloneOlaratumab
Host SpeciesRecombinant
Reactive Specieshuman
IsotypeIgG1 kappa
Formatpurified
Size1mg, 5mg
Concentration1mg/ml
ApplicationsIF, IP, Neut, FuncS, ELISA, FCM
Reviews / RatingsIf you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY.
DescriptionAnti-Human CD140a Recombinant Antibody (Olaratumab). Olaratumab, sold under the brand name Lartruvo, is a monoclonal antibody medication developed by Eli Lilly and Company for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha. It was removed from the United States and European Union markets in 2019, due to insufficient proof of its medical advantage (see below "Medical uses").
Immunogenn/a
Other NamesAnti-CD140a Recombinant Antibody, Research Grade Olaratumab, Anti-Human CD140a Recombinant Antibody(Olaratumab), 3G3, IMC-3G3, LY3012207, Antibody Drug Analogues, Monoclonal Antibody, YR1233, Research Grade Biosimilars, Biosimilar Antibody
Gene, Accession #CAS: 1024603-93-7
Catalog #YR1233
Priceplease inquire
Order / More InfoCD140a, Human (Olaratumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Product Specific Referencesn/a
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806

info@kmdbioscience.com
Sales: sales@kmdbiosci.com

https://www.kmdbioscience.com

Profile of KMD BIOSCIENCE CO. LTD.
Return to Antibodies

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.